Population screening for colorectal cancer: Advantages and drawbacks

Digestive Diseases

Volumn 25, Issue 3, 2007, Pages 270-273

  Kronborg, Ole ^a,c   Regula, Jaroslaw ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c NONE   (Denmark)

Author keywords

Colonoscopy; Colorectal cancer, screening; Computed tomographic colonoscopy; Double contrast barium enema; Fecal DNA; Fecal occult blood tests; Flexible sigmoidoscopy; Population screening, advantages and drawbacks

Indexed keywords

BARIUM ENEMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONFERENCE PAPER; DNA DETERMINATION; DOUBLE CONTRAST RADIOGRAPHY; EXPERT SYSTEM; FECES ANALYSIS; HUMAN; OCCULT BLOOD TEST; POPULATION RESEARCH; PRIORITY JOURNAL; REPEAT PROCEDURE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIGMOIDOSCOPY; ARTICLE; CHEMISTRY; COLON; COLORECTAL TUMOR; FECES; MASS SCREENING; METHODOLOGY; OCCULT BLOOD; RADIOGRAPHY;

BARIUM SULFATE; DIAGNOSTIC AGENT; DNA; ENEMA;

BARIUM SULFATE; COLON; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLORECTAL NEOPLASMS; DNA; ENEMA; FECES; HUMANS; MASS SCREENING; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 35449007689     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103899     Document Type: Conference Paper

References (20)

1. Mandel JS, Bond JH, Church TR, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-1371.
2. Hardcastle JD, Chamberlain JO, Robinson MH, et al: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-1477.
3. Kronborg O, Fenger C, Olsen J, et al: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-1471.
4. Mandel JS, Church TR, Bond JH, et al: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-1607.
5. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-2714.
6. Selby JV, Friedman GD, Quesenberry CR, Weiss NS: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-657.
7. Newcomb PA, Norfleet RG, Storer BE, Surawicz T, Marcus PM: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-1575.
8. Kavanagh AM, Giovanucci EL, Fuchs CS, Colditz GA: Screening endoscopy and risk of colorectal cancer in US men. Cancer Causes Control 1998;9:455-462.
9. Thiis-Evensen E, Hoff GS, Sauer J, Langmark F, et al: Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Scand J Gastroenterol 1999;34:414-420.
10. Winawer SJ, Zauber AG, Ho MN, et al: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-1981.
11. Lieberman DA, Weiss DG, Bond JH, et al: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162-168.
12. Imperiale TF, Wagner DR, Lin CY, et al: Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-174.
13. Strul H, Kariv R, Leshno M, et al: The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years. Am J Gastroenterol 2006;101:255-262.
14. Schoenfeld P, Cash B, Flood A, et al: Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005;352:2061-2068.
15. Regula J, Rupinski M, Kraszewska E, et al: Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-1872.
16. Scheitel SM, Ahlquist DA, Wollan PC, et al: Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. Mayo Clin Proc 1999;74:1207-1213.
17. Hakama M, Hoff G, Kronborg O, Påhlman L: Screening for colorectal cancer. Acta Oncologica 2005;44:425-439.
18. Fraser CG, Matthew CM, Mowat NAG, Wilson JA, Carey FA, Steele RJC: Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Lancet Oncol 2006;7:127-131.
19. Kronborg O: Screening for colorectal cancer in the average-risk population. Semin Colon Rect Surg 2002;13:16-30.
20. Nicholson FB, Barro JL, Atkin W, Lilford R, Patrick J, Williams CB, Pignone M, Steele R, Kamm MA: Review article: population screening for colorectal cancer. Aliment Pharmacol Ther 2005;22:1069-1077.